These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 15617028)
1. Androgen receptor mutants detected in recurrent prostate cancer exhibit diverse functional characteristics. Chen G; Wang X; Zhang S; Lu Y; Sun Y; Zhang J; Li Z; Lu J Prostate; 2005 Jun; 63(4):395-406. PubMed ID: 15617028 [TBL] [Abstract][Full Text] [Related]
2. An S296R mutation in the human androgen receptor causes activation of the receptor by non-androgenic steroids and stronger inhibition by the nuclear receptor corepressor N-coR. Li YD; Lu Y; Chen GC; Lu J Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1252-7. PubMed ID: 18637017 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455 [TBL] [Abstract][Full Text] [Related]
4. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Koivisto P; Kononen J; Palmberg C; Tammela T; Hyytinen E; Isola J; Trapman J; Cleutjens K; Noordzij A; Visakorpi T; Kallioniemi OP Cancer Res; 1997 Jan; 57(2):314-9. PubMed ID: 9000575 [TBL] [Abstract][Full Text] [Related]
8. Androgen receptor gene mutations in hormone-refractory prostate cancer. Wallén MJ; Linja M; Kaartinen K; Schleutker J; Visakorpi T J Pathol; 1999 Dec; 189(4):559-63. PubMed ID: 10629558 [TBL] [Abstract][Full Text] [Related]
9. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977 [TBL] [Abstract][Full Text] [Related]
11. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor gene amplification and protein expression in recurrent prostate cancer. Ford OH; Gregory CW; Kim D; Smitherman AB; Mohler JL J Urol; 2003 Nov; 170(5):1817-21. PubMed ID: 14532783 [TBL] [Abstract][Full Text] [Related]
13. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Tilley WD; Buchanan G; Hickey TE; Bentel JM Clin Cancer Res; 1996 Feb; 2(2):277-85. PubMed ID: 9816170 [TBL] [Abstract][Full Text] [Related]
14. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. Yang Q; Titus MA; Fung KM; Lin HK J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593 [TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Zhao XY; Malloy PJ; Krishnan AV; Swami S; Navone NM; Peehl DM; Feldman D Nat Med; 2000 Jun; 6(6):703-6. PubMed ID: 10835690 [TBL] [Abstract][Full Text] [Related]
16. The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor. Haelens A; Tanner T; Denayer S; Callewaert L; Claessens F Cancer Res; 2007 May; 67(9):4514-23. PubMed ID: 17483368 [TBL] [Abstract][Full Text] [Related]
17. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines. Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014 [TBL] [Abstract][Full Text] [Related]
18. Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells. Dehm SM; Regan KM; Schmidt LJ; Tindall DJ Cancer Res; 2007 Oct; 67(20):10067-77. PubMed ID: 17942941 [TBL] [Abstract][Full Text] [Related]
19. Interrogating androgen receptor function in recurrent prostate cancer. Zhang L; Johnson M; Le KH; Sato M; Ilagan R; Iyer M; Gambhir SS; Wu L; Carey M Cancer Res; 2003 Aug; 63(15):4552-60. PubMed ID: 12907631 [TBL] [Abstract][Full Text] [Related]
20. [Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer]. Castagnaro M; Yandell DW; Dockhorn-Dworniczak B; Wolfe HJ; Poremba C Verh Dtsch Ges Pathol; 1993; 77():119-23. PubMed ID: 7511268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]